|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improving stem cell mobilization strategies: future directions 显示文摘 | Bensinger W DiPersio JF McCarty JM | 2009 | Bone MarrowTransplant2009，43，3： | 1 |
| 2 | Phase III prospec tive randomized double-blind placebo-controlled trial of plerixafor plus granuloeyte colony- stimulating factor compared with placebo plus granulocyte colony-stimula- ting factor for autologous stem-cell mobilization and transplantation for patients With non-Hodgkins lymphoma显示文摘 | DiPersio JF Mieallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 3 | Update on clinical experience with amda100,an sdf-1/cxc1l2-cxcr4 inhibitor,in mobilization of hematopoietic stem and progenitor cells显示文摘 | Pusic I DiPersio JF | 2010 | Curr Opin Hematol2010，17，4： | 1 |
| 4 | Plerix- afor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem transplanta- tion in patients with multiple myetoma显示文摘 | DiPersio JF Stadtmauer EA Nademanee A | 2009 | Blood2009，113，23： | 1 |
| 5 | Novel strategies for hematopoietic stem cell mobilization 显示文摘 | Devine SM Link D DiPersio JF | 2004 | Current Opinion in Organ Transplantation2004，9，1： | 1 |
| 6 | A Phase Ⅲ , multicenter, randomized, double- blind, placebo controlled, comparative trial of AMD3100 (plerixafor) + G-CSF vs placebo + G-CSF in non- Hodgkin's-lymphoma (NHL) patients for autologous hematopoieticstem cell (aHSC) transplantation 显示文摘 | DiPersio JF | 2007 | ASH Annual Meeting Abs2007，110，： | 1 |
| 7 | A phase Ⅲ , multicenter, randomized, double- blind, placebo controlled, comparative trial of AMD3100 (Plerixafor) + G-CSF vs G-CSF + placebo for mobilization in multiple myeloma (MM) patients for autologous hematopoieticstem cell (aHSC) transplantation 显示文摘 | DiPersio JF | 2007 | ASH Annual Meeting Abs2007，110，： | 1 |
| 8 | Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation显示文摘 | Graubert TA DiPersio JF Russell JH | 1997 | J Clin Invest1997，100，4： | 1 |
| 9 | A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies 显示文摘 | RIZZIERI DA FELDMAN E DIPERSIO JF | 2008 | Clin Cancer Res2008，14，9： | 1 |
| 10 | Update on clinical experience with AMD3100,an SDF-1/CXCL12-CXCR4 inhibitor,in mobilization of hematopoietic stem and progenitor cells显示文摘 | Pusic I DiPersio JF | 2010 | Curr Opin Hematol2010，17，4： | 1 |
| 11 | Mouse models of graft-ver- sus-host disease: advances and limitations显示文摘 | Schroeder MA DiPersio JF | 2011 | Dis Model Mech2011，4，3： | 1 |
| 12 | Diabetic stem-cell 'mobilopathy' 显示文摘 | Dipersio JF | 2011 | N Engl J Med2011，365，26： | 1 |
| 13 | Phase III prospective ran- domized double-blind placebo-controlled trial for plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mo- bilization and transplantation for patients with non-Hodgkin's lyre-phoma显示文摘 | DiPersio JF Micallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 14 | The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to Co-CSF alone显示文摘 | Flomenbexg N Devine SM DiPersio JF | 2005 | Blood2005，106，： | 1 |
| 15 | Improving stem cellmobilization strategies: future directions 显示文摘 | Bensinger W Dipersio JF Mccarty JM | 2009 | Bone MarrowTransplant2009，43，3： | 1 |
| 16 | Successful stem cell mobilization rescue by AMD3100 (Perixafor) + G-CSF for patients who failed primary mobilization: results from the phase Ⅲ (3101-NHL) study显示文摘 | Micallef I Stiff P DiPersio JF | 2007 | Blood2007，110，： | 1 |
| 17 | Mouse models of graft-versus-host disease: advances and limitations显示文摘 | Bchroeder MA DiPersio JF | 2011 | Ibis Model Mech2011，4，3： | 1 |
| 18 | Phase Ⅲ prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma显示文摘 | DiPersio JF Micallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 19 | Therapy options in imatinib fail- ures显示文摘 | Ramirez P DiPersio JF | 2008 | Oncologist2008，13，4： | 1 |
| 20 | A phase 2clinical trial of deforolimus(AP23573,MK-8669),a novel mammalian target of rapamycin inhibitor,in patients with relapsed or refractory hematologic malignancies显示文摘 | Rizzieri DA Feldman E Dipersio JF | 2008 | Clin Cancer Res2008，14，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员